BioElectronics Corporation Discusses Q2 Financials

Revenue Growth Exceeds 665% FREDERICK, MARYLAND, Aug. 30, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation ( OTC: BIEL) said today that it would like to clarify information about the Company and acknowledge the investor community’s request for comments following Q2 financials. Key facts from the Q2 financials many of which were found in the footnotes: The … Continue Reading

BioElectronics Chairman Outlines New Direction for Company

FREDERICK, MD, Aug. 10, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – BioElectronics Corporation (OTC: BIEL), ( today released a Chairman’s Letter to Shareholders written by Dr. Richard Staelin, the Company’s Chairman of the Board. Dear BioElectronics Shareholders : The purpose of this letter is to update you on the activities of BioElectronics Corporation over the … Continue Reading

BioElectronics Announces Expanded Menstrual Pain Study

FREDERICK, MD, Jan. 16, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), is pleased to announce the commencement of an independent clinical study to investigate the efficacy of the Allay® Menstrual Pain device. The study will be take place at the prestigious United Kingdom Birmingham Women’s NHS Foundation Trust. Primary dysmenorrhea (menstrual pain) … Continue Reading

UpTick News Wire Radio Show Will Interview BioElectronics’ CEO Andrew Whelan

Topics will Include UK Market Expansion and US FDA Status FREDERICK, MD. November 4, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management announced that Andrew J. Whelan, President will be interviewed by Stu Taylor on his program “On Business“ at 9am EST on Thursday, November 5th. To … Continue Reading